| Date | Title | Description |
| 17.02.2021 | The Government Can — And Should — Send High-Quality Masks To... | Link to full article from The Washington Post
As more-contagious variants of the coronavirus spread... |
| 08.11.2020 | A National COVID-19 Confidence Project: Job No. 1 For Presid... | Full article from STAT News
President-elect Joe Biden faces many grave challenges. The one we belie... |
| 22.10.2020 | Protecting Biomedical Innovation as A National Security Asse... | Full article from BioCentury
In recent years, it has become fashionable to focus on the high price ... |
| 20.10.2020 | Essential Workers Need Better Masks | Link to full article from HBR
With a vaccine still months away for most people in the United States... |
| 16.09.2020 | David Beier Op-Ed: Vaccine Hesitancy: Why American Values Ma... | Link to full article from BioCentury
More than a third of Americans tell polls they would not take ... |
| 21.07.2020 | David Beier Op-Ed: The Time Has Come for a Major National Ef... | Full article from Medium
We the undersigned, scientists and public health advocates, urge public of... |
| 18.06.2020 | David Beier Op-Ed: We Need Better Masks | Link to full in article from HBR
With 21 U.S. states experiencing a rise in Covid-19 cases just wee... |
| 01.05.2020 | David Beier Op-Ed: A Plan to Safely Reopen the U.S. Despite ... | Link to full article from HBR
For regions shut down due to Covid-19 to safely begin to reopen, we n... |
| 26.02.2020 | David Beier Op-Ed: We Need a Cheap Way to Diagnose Coronavir... | Link to full article from HBR
Covid-19, the new coronavirus, is on the verge of spreading across th... |
| 19.02.2020 | David Beier Op-Ed: A New Drug Pricing Social Contract: The G... | Article from Medium
In The Great American Drug Deal, biotech investor Peter Kolchinsky outlines a v... |
| 23.01.2020 | Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™... | Link to full release from Epizyme
CAMBRIDGE, Mass.–(BUSINESS WIRE)– Epizyme, Inc. (Nasdaq: EPZM), a... |
| 14.01.2020 | Innovation in biotech R&D: New resources offer new hope | Link to full Op Ed on STAT NEWS
Public optimism about American health care seems in short supply if... |
| 10.01.2020 | Lilly Announces Agreement to Acquire Dermira | Link to full article from Dermira |
| 07.01.2020 | Galecto and PharmAkea Merge to Create Strong Clinical-Stage ... | Link to full release from GlobeNewswire
Galecto, the leading developer of galectin modulators for t... |
| 07.01.2020 | Galecto and PharmaKea merge to create strong clinical-stage ... | Link to full press release from Galecto
San Diego, CA/Copenhagen, Denmark, January 7, 2020 – Galect... |
| 07.01.2020 | Galecto to merge with onetime Celgene partner PharmAkea | https://www.fiercebiotech.com/biotech/galecto-to-merge-one-time-celgene-partner-pharmakea
Galecto i... |
| 10.12.2019 | Dermira Receives Fast Track Designation from FDA for Lebriki... | Full article from Dermira
MENLO PARK, Calif.–(BUSINESS WIRE)– Dermira, Inc. (NASDAQ: DERM), a bioph... |
| 26.09.2019 | David Beier Op-Ed: A Plan to Address California’s Quiet Cris... | Link to full article in Medium
California’s kids are in crisis, and the issue isn’t getting the att... |
| 25.09.2019 | Blade Therapeutics Expands Anti-Fibrotic Pipeline With Acqui... | Link to full release from Blade
Blade Therapeutics, a biopharmaceutical company advancing novel ant... |
| 27.08.2019 | Synchronicity Pharma Highlights New Research Demonstrating B... | Read full article from Synchronicity Pharma
San Francisco August 27, 2019 – Synchronicity Pharma (“... |
| 27.06.2019 | Almirall Exercises its Option with Dermira to License Rights... | Read full release on Dermira’s website
BARCELONA, Spain & MENLO PARK, Calif.–(BUSINESS WIRE)–Ju... |
| 07.05.2019 | David Beier Op-Ed: Time for Action on America’s Sleep Crisis... | Link to full article on Medium.com
Sleep deprivation is killing us.
More than one third of America... |
| 19.03.2019 | David Beier Op-Ed: FDA Reform: It’s Time To Act, But Not As ... | Link to full article on Health Affairs
In a rare exercise in bipartisan leadership, former Food a... |
| 25.01.2019 | David Beier Op-Ed: The Midterm’s Biggest Winners: Medicaid A... | Link to full article
Voters in the 2018 midterm, especially in rural America, offered a ringing end... |
| 04.01.2019 | Artificial Intelligence keeps Gov.-elect Newsom up at night.... | Article from The Sacramento Bee
An out of control trolley rushes toward five people tied to the tra... |
| 20.12.2018 | David Beier Op-Ed: The right way to address prescription dru... | Link to article at Stat News
With a new Democratic majority in the House pledging to address the ri... |
| 26.11.2018 | David Beier Op-Ed: How business leaders of the world can uni... | Full article at South China Morning Post
The ongoing US-China trade war bodes poorly for global eco... |
| 24.10.2018 | David Beier Appointed to NAM Action Collaborative | David Beier is pleased to be appointed to join public health colleagues in an Action Collaborative e... |
| 12.10.2018 | Dermira Provides Launch Readiness Update for QBREXZA™ (glyco... | Full article from Dermira
MENLO PARK, Calif., Sept. 5, 2018 – Dermira, Inc. (NASDAQ: DERM), a bioph... |
| 14.09.2018 | David Beier Op-Ed: Advancing Health in California | Full article in Medium
“One of the biggest problems in healthcare,” says Diana Dooley, chief of sta... |
| 14.09.2018 | David Beier and Andrew Sullivan Op-Ed: Russian bots are taki... | Full article in STAT News
It almost makes sense, in a most devious way, that the Russian government... |
| 29.06.2018 | Dermira Receives FDA Approval for Qbrexza™ (glycopyrronium) ... | Link to full article from Dermira
MENLO PARK, Calif., June 29, 2018 (GLOBE NEWSWIRE) — Dermira, Inc... |
| 22.06.2018 | David Beier Op Ed: America’s human infrastructure is the key... | Full article in The Hill
When the Soviet Union’s Sputnik satellite entered the earth’s orbit in 195... |
| 15.06.2018 | David Beier Op-Ed: America’s human infrastructure is the key... | Link to full article in The Hill
When the Soviet Union’s Sputnik satellite entered the earth’s orbi... |
| 31.05.2018 | Madrigal Achieves Liver Biopsy Endpoints in Patients with NA... | Full article from Madrigal Pharmaceuticals
CONSHOHOCKEN, Pa., May 31, 2018 — Madrigal Pharmaceutica... |
| 23.05.2018 | David Beier Op Ed: Trump’s Drug Pricing Plan: A Web of Contr... | Full article in Morning Consult
President Donald Trump has offered a comprehensive set of policies ... |
| 20.04.2018 | Incentives in Drug Development: Orphan Drugs & Antibioti... | David Beier & Dayton Misfeldt
April 23, 2018
University of California Berkeley |
| 20.04.2018 | David Beier Op-Ed: On drug pricing, Trump could rely on blus... | Full article in Stat News
As President Trump prepares to give a speech next week to address the iss... |
| 06.04.2018 | Biosimilar Drugs: Panacea for Health Care Costs? Not Exactly | This article is an edited version of a longer piece on biosimilars. For those interested in more det... |
| 08.03.2018 | Infinity Pharmaceuticals Announces Additions to Board of Dir... | CAMBRIDGE, Mass., March 8, 2018 /PRNewswire/ — Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announc... |
| 14.02.2018 | Twist Bioscience Launches Exome and Custom Target Enrichment... | - |
| 25.01.2018 | Menlo Therapeutics Inc. Announces Pricing of Initial Public ... | - |
| 10.01.2018 | Governor Brown Announces: David Beier Appointment to the Lit... | Announcement at CA.Gov
David Beier, 69, of San Francisco, has been reappointed to the Milton Marks ... |
| 07.01.2018 | WuXi Global Forum 2018 – A Celebration of Global Partnership... | David Beier
January 9, 2018
San Francisco, CA
Event link |
| 06.01.2018 | Sachs Neuroscience Innovation Forum | Investor Roundtable
Manuel Lopez
January 7, 2018
San Francisco, CA |
| 04.01.2018 | Madrigal: This Year’s Best Midcap Stock Was Virtually Unknow... | Article in Bloomberg
Madrigal Pharmaceuticals Inc. — a player in the blockbuster contest to develop... |
| 04.01.2018 | David Beier Op-Ed: The NIH is in danger of losing its edge i... | Article in Stat News
In Ernest Hemingway’s “The Snows of Kilimanjaro,” the protagonist dies from an... |
| 19.12.2017 | Madrigal Pharmaceuticals Prices Public Offering of Common St... | Release at Yahoo Finance
CONSHOHOCKEN, Pa., Dec. 18, 2017 (GLOBE NEWSWIRE) — Madrigal Pharmaceutica... |
| 18.12.2017 | Arcus Biosciences Appoints David Beier to Board of Directors | Article at CNBC
HAYWARD, Calif.–(BUSINESS WIRE)– Arcus Biosciences, a clinical stage biopharmaceuti... |
| 06.12.2017 | Madrigal’s MGL-3196 Achieves Primary Endpoint in Patients wi... | Full Press Release from Madrigal
— Statistically significant improvement in the relative decrease i... |
| 30.11.2017 | David Beier Op-Ed: What Trump’s Health Secretary Needs to An... | Article in Morning Consult
Ten months ago, we wrote about Health and Human Services nominee Tom Pri... |
| 30.11.2017 | David Beier Op-Ed: Drug price reforms that limit incentives ... | Article in Stat News
The ongoing furor over the price of prescription pharmaceuticals has become so... |
| 14.11.2017 | PLENARY: A New Generation of Philanthropy Joins the Battle A... | David Beier
November 14, 2017
San Francisco, CA
Event link |
| 09.11.2017 | David Beier Op-Ed: A Tax on Robots Is a Tax on Jobs | Article from Inside Sources
Legendary baseball player and fractured linguist Yogi Berra is claimed ... |
| 06.11.2017 | David Beier Quoted in STAT Article: They had power and statu... | Link to STAT post
PALO ALTO, Calif. — It’s easy to think, from the headlines, that the future of he... |
| 01.11.2017 | A State of Emergency: Integrative Approaches to Addiction an... | - |
| 10.10.2017 | WSGR: Healthcare Innovations Venture Investment Forum | Carl Goldfischer, Matt Kronmiller
December 6 - 8, 2017
Austin, Texas |
| 28.09.2017 | Immunogenomics 2017 | Shaping The Future of Human Health
Fred Craves, Manuel Lopez, and Minqi Li
October 2 - 4, 2017
Hu... |
| 14.09.2017 | New CIMZIA® Findings Presented at European Academy of Dermat... | - |
| 13.09.2017 | Dermira Presents New Data Showing Impact of Primary Axillary... | MENLO PARK, Calif., Sept. 13, 2017 — Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedic... |
| 28.08.2017 | CLSA Expands Board Of Directors With Industry And Academic L... |
SAN FRANCISCO and SAN DIEGO – California Life Sciences Association (CLSA), the statewide public po... |
| 01.08.2017 | David Beier Op-Ed: Pharma and the Opioid Crisis: In Search o... | Article in Morning Consult
|
| 21.07.2017 | Dayton Misfeldt Op-Ed: Orphan Diseases Or Population Health?... | Article in Health Affairs
The US exhibits a remarkable pipeline of biopharmaceutical innovation, wi... |
| 09.07.2017 | 10th China Biotechnology Industry Conference – the Biomedica... | GF Securities, GF Xinde Investment Management Co., Ltd. (“GF Xinde”) and Bay City Capital, LLC (“Bay... |
| 09.07.2017 | Bay City Capital and GF Xinde Announce Collaboration on Uniq... | GF Securities, GF Xinde Investment Management Co., Ltd. (“GF Xinde”) and Bay City Capital, LLC (“Bay... |
| 06.07.2017 | David Beier Op-Ed: China Set To Accelerate Life Science Inno... | Article in Forbes
|
| 16.06.2017 | David Beier Op-Ed: Reform Prescription Drug Labeling to Bene... | https://morningconsult.com/opinions/reform-prescription-drug-labeling-benefit-patients-doctors/ |
| 24.05.2017 | David Beier Op-Ed: What President Trump can learn from Gov. ... | Article in The Sacramento Bee
|
| 18.05.2017 | David Beier Op-Ed: Human Genome Editing: Who Gets to Decide? | Article in Scientific American
|
| 16.05.2017 | David Beier Op-Ed: Why Are The Children Crying? | Article in Morning Consult
|
| 01.05.2017 | David Beier Op-Ed: Understanding Of Cell Biology By Creating... | Article in Medium
|
| 03.04.2017 | Cydan Development Announces the Acquisition of Its First Rar... | Link to Release
Cambridge, Mass., April 3, 2017 – Cydan Development, Inc., an orphan drug acceler... |
| 27.03.2017 | Bridge Medicines Appoints William J. Polvino, M.D., As Chief... | New York, NY — Bridge Medicines, a pioneering drug discovery company focused on advancing promising ... |
| 21.03.2017 | Omicia Rebrands as Fabric Genomics | Oakland, CA and Phoenix, AZ — Omicia today announced that it has rebranded and renamed the organizat... |
| 16.03.2017 | Merus Named BioCapital Europe 2017 Company of the Year | Utrecht, The Netherlands — Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company develo... |
| 15.03.2017 | David Beier Op-Ed: The World Is Completely Unprepared for a ... | Article in Harvard Business Review
In 2003 a doctor with SARS unknowingly infected several guests w... |
| 03.03.2017 | David Beier Op-Ed: Drug Price Transparency Bill Will Not Low... | Article in SF Chronicle |
| 08.02.2017 | 10th European Life Science CEO Forum | Private Equity and VC Panel
Lionel Carnot
March 6-7, 2017
Zurich, Switzerland
Event link |
| 07.02.2017 | Epizyme Elects Kevin Conroy to its Board of Directors | Cambridge, MA — Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating nov... |
| 20.01.2017 | Accriva Diagnostics Acquired by Werfen and Instrumentation L... | http://www.accriva.com/uploads/assets/Press-Release-Issued-by-Accriva-January-20-2017-FINAL.pdf
Acc... |
| 20.01.2017 | Accriva Diagnostics Acquired by Werfen and Instrumentation L... | San Diego, CA — Accriva Diagnostics, a Warburg Pincus portfolio company, announced today the definit... |
| 21.12.2016 | Incyte and Merus Announce Global Strategic Research Collabor... | Wilmington, DE and Utrecht, The Netherlands – Incyte Corporation (NASDAQ:INCY) and Merus N.V. (NASDA... |
| 29.11.2016 | Vtesse Receives Rare Pediatric Disease Designation for VTS-2... | Gaithersburg, MD — Vtesse, Inc., a company committed to developing medicines to benefit patients wit... |
| 18.11.2016 | PharmAkea Extends Collaboration with Celgene Corporation | San Diego, CA — PharmAkea Inc. announced the extension of their strategic collaboration with Celgene... |
| 15.11.2016 | Merus Announces Favorable Decisions in Europe and Japan for ... | Utrecht, The Netherlands — Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company develo... |
| 03.11.2016 | Interleukin Genetics Launches The ILUSTRA™ Inflammation Mana... | Waltham, MA — Interleukin Genetics, Inc. (OTCQB:ILIU) a life science company focused on the genetics... |
| 31.10.2016 | Bay City Capital Partners with TDI, Takeda and Deerfield Man... | New York, NY and Osaka, Japan — Memorial Sloan Kettering Cancer Center, The Rockefeller University a... |
| 20.10.2016 | Madrigal Pharmaceuticals Announces the Initiation of a Phase... | Conshohocken, PA — Madrigal Pharmaceuticals, Inc. (MDGL) today announced that the first patient has ... |
| 19.10.2016 | Merus Receives Milestone Payment from Ono Pharmaceutical for... | UTRECHT, The Netherlands — Merus N.V. (NASDAQ: MRUS), a clinical-stage immuno-oncology company devel... |
| 11.10.2016 | Cydan Announces the Promotion of James McArthur, Ph.D. to Pr... | Cambridge, MA — Cydan Development, Inc., an orphan drug accelerator dedicated to creating therapies ... |
| 19.09.2016 | EnteroMedics Announces Receipt of Notice of Intention to Gra... | St. Paul, MN — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblockin... |
| 15.09.2016 | Epizyme Earns $6 Million Milestone Payment from GlaxoSmithKl... | Cambridge, MA — Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating nov... |
| 14.09.2016 | Alexandria Summit – Healthcare Economics 2016 | David Beier
September 14-15, 2016
New York, NY
Event link |
| 06.09.2016 | Nevro Announces Two-Year SENZA-RCT Results in Neurosurgery | Redwood City, CA — Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innov... |
| 24.08.2016 | First Closing Of The Earlybird Health Tech Fund | Berlin, Germany — Earlybird Venture Capital (www.earlybird.com) announces the first closing of its E... |
| 03.08.2016 | Interleukin Genetics Strengthens Commercial Leadership with ... | Waltham, MA — Interleukin Genetics, Inc. (OTCQB: ILIU), a life science company focused on the geneti... |
| 01.08.2016 | Interleuken Genetics Announces $5.6M Financing | Waltham, MA — Interleukin Genetics, Inc. (OTCQB: ILIU), a life sciences company focused on developin... |
| 26.07.2016 | Vtesse Secures Additional $17M in Series A Extension | Gaithersburg, MD – Vtesse, Inc. a company committed to developing drugs that will benefit patients w... |
| 22.07.2016 | Madrigal Pharmaceuticals Completes Merger with Synta | Fort Washington, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutic... |
| 12.07.2016 | Interleukin Genetics To Offer Inflammation Management Progra... | Waltham, MA — Interleukin Genetics, Inc. (OTCQB: ILIU), a life sciences company focused on the genet... |